Skip to content

Promoting Successful Weight Loss in Primary Care in Louisiana Using Information Technology

Promoting Successful Weight Loss in Primary Care in Louisiana Using Information Technology

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05523375
Acronym
PROPEL-IT
Enrollment
352
Registered
2022-08-31
Start date
2022-08-29
Completion date
2026-02-28
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2, Obesity, PreDiabetes

Brief summary

The primary aim is to test the effectiveness of an innovative 24-month pragmatic and scalable weight-loss centric approach using a collaborative care model that connects patients with a non-Primary Care Practitioner (PCP) health coach who delivers care remotely to patients through the patient portal of an electronic medical record (EMR).

Detailed description

This study is a 24-month, two-arm, parallel controlled trial in a primary care setting. A total of 352 Black adults with obesity and type 2 diabetes or prediabetes will be randomized to either 1) intervention or 2) usual care. The intervention arm will receive a comprehensive, "high-intensity" program, as recommended first-line therapy by the 2013 American Heart Association/American College of Cardiology/The Obesity Society Obesity Guidelines, delivered remotely using eHealth technology, by trained health coaches embedded in the Digital Medicine Group in the Ochsner Health System. The intervention will include remote sessions with the health coach using evidence-based components such as the use of portion control and various behavioral strategies. Patients in the usual care arm will receive their normal, usual care from their primary care team. All patients will participate in the collection of patient-reported outcomes at baseline and approximately 6, 12, and 24 months.

Interventions

BEHAVIORALIntensive Lifestyle Intervention

Trained health coaches deliver the active intervention - a comprehensive, "high-intensity" program, as recommended first-line therapy by the 2013 American Heart Association/American College of Cardiology/The Obesity Society Guidelines.

Sponsors

Pennington Biomedical Research Center
Lead SponsorOTHER
National Institute on Minority Health and Health Disparities (NIMHD)
CollaboratorNIH
University of Alabama at Birmingham
CollaboratorOTHER
Ochsner Health System
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* 40-70 years of age * Self-identify as Black/African American * Obesity (BMI 30.0-50.0 kg/m2) * Type II diabetes (based on ICD-10 codes, fasting plasma glucose ≥126 mg/dL, HbA1c ≥6.5%, 2-h plasma glucose during 75-g Oral Glucose Tolerance Test (OGTT) ≥200 mg/dL, or a random plasma glucose ≥200 mg/dL in a patient with classic symptoms of hyperglycemia or hyperglycemic crisis) or pre-diabetes (based on ICD-10 codes, fasting glucose 100-125 mg/dL or HbA1c 5.7-6.4% or 2-h glucose during 75-g OGTT 140-199 mg/dL) * Has an internet-connected device and is willing to use it for intervention delivery * Patient in the Ochsner Health System with an active MyOchsner portal account, or willing to create one * Acknowledgement from their Ochsner primary care practitioner that there are no known contraindications to the patient's participation * Have weight measured at an Ochsner clinic within 4 weeks of screening * Resident of Louisiana * Be able to provide informed consent * Willing to change diet and/or physical activity

Exclusion criteria

* Body weight ≥ 400 lbs. * Current use of weight loss medication or recent weight loss (net loss \>10 lbs in the last six months) * Currently participating in a structured weight loss program * Plans to move from the area within 2 years * Given birth within the past year, is currently pregnant or breastfeeding or plans to become pregnant within 2 years * Past bariatric surgery or plans for bariatric surgery within 2 years * Disease/condition that is life threatening or can interfere with or be aggravated by exercise or weight loss

Design outcomes

Primary

MeasureTime frameDescription
Body weight (Percent Change)Percent (%) Change from Baseline to Month 24Body weight is measured in light indoor clothes and is obtained from the electronic medical record.

Secondary

MeasureTime frameDescription
Body weight (kg)Change in kg from Baseline to Month 24Body weight is measured in light indoor clothes and is obtained from the electronic medical record.
Systolic Blood PressureChange from Baseline to Month 24Resting systolic blood pressure is measured and is obtained from the electronic medical record.
Diastolic Blood PressureChange from Baseline to Month 24Resting diastolic blood pressure is measured and is obtained from the electronic medical record.
HbA1cChange from Baseline to Month 24HbA1c levels are assayed and are obtained from the electronic medical record.
Total CholesterolChange from Baseline to Month 24Total cholesterol levels are assayed and are obtained from the electronic medical record.
High-density Lipoprotein (HDL) CholesterolChange from Baseline to Month 24HDL cholesterol levels are assayed and are obtained from the electronic medical record.
TriglyceridesChange from Baseline to Month 24Triglyceride levels are assayed and are obtained from the electronic medical record.
Low-density Lipoprotein (LDL) cholesterolChange from Baseline to Month 24LDL cholesterol levels are estimated using the Friedewald equation and are obtained from the electronic medical record.
Physical ActivityChange from Baseline to Month 24Physical activity is measured using the International Physical Activity Questionnaire-SF questionnaire.
Dietary IntakeChange from Baseline to Month 24Dietary intake is measured using National Cancer Institute Dietary Screeners.
Impact of Weight on Quality of Life-Lite-Clinical Trials QuestionnaireChange from Baseline to Month 24Items are scored 1-5 (never true to completely true). Scores are obtained on 3 composite scales (Physical, Physical Function, and Psychosocial), as well as total score. The raw composite score is calculated as the average of non-missing responses within each composite, then transforming to a 0-100 scale (worst to best). Composite scores and total score range from 0 to 100, where 100 represents higher levels of functioning.
EuroQol-5 Dimension QuestionnaireChange from Baseline to Month 24Each of 5 questions can have a response ranging from 1-5 (none to extreme). These are then concatenated into one of 3125 "health states" (i.e. 11231, 52454, etc.) An EQ-5D summary index is derived by applying a formula that attaches values (weights) to each of the levels in each dimension to create a value set. Lower scores indicate better health.
Health Care Utilization QuestionnaireChange from Baseline to Month 24Health care utilization is measured using a brief 4-item questionnaire with continuous responses (how many times did you go to the doctor, go to Emergency Room, stay overnight, # nights). Each question is analyzed separately.
Perceived Stress Scale-4 QuestionnaireChange from Baseline to Month 24The Perceived Stress Scale has 4 questions with responses ranging from 0-4 (Never to Very Often). Total (sum) score range is 0-16, with a higher score correlating to more stress.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORPeter T Katzmarzyk, PhD

Pennington Biomedical Research Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026